Accounts Payable

6 Months Ended

Jun. 30, 2022

Accounts Payable

Accounts Payable

5.            Accounts Payable

As of June 30, 2022, current liabilities included accounts payable of $0.6 million, comprised primarily of amounts owed for drug supply manufacturing of $0.3 million, clinical trial expenses of $0.2 million and legal and patent fees of $0.1 million. As of December 31, 2021, current liabilities included accounts payable of $0.1 million, comprised primarily of legal and patent fees and expenses related to manufacturing totaling $0.1 million.